Search

Search Results
Results 3941 - 3950 of 8655 for allergy
  • Discovery of new virus
    News - 24 Apr 2007
    Scientists in the Greene Infectious Disease Laboratory of the Columbia University Mailman School of Public Health and colleagues in the Victorian Infectious Diseases Reference Laboratory in Melbourne,...
  • FDA wants warning label on omalizumab (Xolair)
    News - 21 Feb 2007
    The Food and Drug Administration (FDA) announced that it has requested Genentech, Inc. add a boxed warning to the product label for omalizumab, marketed as Xolair.
  • siRNA delivery into human T cells and primary cells with carbon-nanotube transporters
    News - 20 Feb 2007
    A promising approach to gene therapy involves short DNA fragments (interfering RNA) that bind to specific genes and block their "translation" into the corresponding, disease-related protein.
  • Emergent BioSolutions awarded $3.8 million to develop anthrax immune globulin therapeutic
    News - 1 Sep 2006
    Emergent BioSolutions has announced that it has been awarded two grants from the National Institute of Allergy and Infectious Diseases (NIAID) totaling $3.8 million to support the development of the...
  • West Nile virus DNA vaccine shows promise in phase 1 trial
    News - 5 Jun 2006
    Vical Incorporated has announced that in a Phase 1 clinical trial, a West Nile virus (WNV) vaccine candidate administered using Vical's proprietary DNA delivery technology was safe and well tolerated
  • Inflammation cuts both ways
    News - 6 Apr 2006
    Inflammation cuts both ways. When invaded by an infectious agent, for example, the body calls on the forces of inflammation to fight and defeat the intruder.
  • Ebola DNA vaccine shows promise
    News - 21 Feb 2006
    Vical Incorporated has announced that an Ebola vaccine candidate administered using Vical's proprietary DNA delivery technology was safe and well tolerated, and produced both antibody and T-cell...
  • Findings may help in development of new anti-inflammatory compounds
    News - 2 Dec 2005
    Virginia Commonwealth University researchers studying the enzyme that triggers inflammation have found that it may be a target for a new class of anti-inflammatory drugs to treat arthritis, asthma,...
  • Blood testing links common foods and irritable bowel syndrome
    News - 13 Jul 2005
    Researchers using comparison trials determined that irritable bowel syndrome (IBS) patients have elevated food-specific IgG4 antibodies to common foods such as wheat, beef, pork, lamb, and soya bean....
  • Meth abuse and curbs on cold medicines
    News - 4 Apr 2005
    As states and Congress rush to put common cold, cough and allergy drugs behind the pharmacy counter to curb illegal methamphetamine production, no one has asked consumers what they think about these...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback